TB-500 Fragment (17-23) 10 mg
Main Image

TB-500 Fragment (17-23) 10 mg

Steroids Dragon Pharma Peptide

$26.40

TB-500 Fragment (17–23) 10 mg – Tissue Repair Peptide by Peptide Hubs

TB-500 Fragment (17–23) is a truncated version of the full-length thymosin beta-4 peptide, designed for enhanced precision in tissue-specific research applications. Offered in a 10 mg/vial (2 mL) format by Peptide Hubs, this peptide fragment has shown potential in promoting cell migration, wound healing, and inflammation modulation in preclinical models.

What Is TB-500 Fragment (17–23)?

This peptide consists of amino acids 17 through 23 of the TB-500 (Thymosin Beta-4) sequence – believed to be the most bioactive domain. By isolating this fragment, researchers can focus on targeted regenerative effects without broader interactions seen with the full-length peptide. It retains actin-binding functionality, crucial for mobilizing cells during tissue recovery and regeneration.

According to research on actin-sequestering peptides, the 17–23 domain may be central to TB-500's biological activities, especially in wound closure and angiogenesis models.

Benefits in Research Settings

  • Enhances cell migration and tissue remodeling
  • Promotes wound healing and recovery
  • Supports vascularization (angiogenesis)
  • Reduces inflammatory response in damaged tissue
  • High bioactivity in a focused sequence
Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Dragon Pharma
Manufacturer: Dragon Pharma
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines</h2> <p>In preclinical animal studies, TB-500 Fragment (17–23) is used at doses of <strong>2–5 mg per week</strong>, administered subcutaneously or intramuscularly. Typical research durations range from 2 to 4 weeks depending on the tissue recovery model. Due to its small molecular size, this fragment is rapidly absorbed and acts systemically.</p> <h3>Recommended Stack for Advanced Peptide Studies</h3> <p>For enhanced results in tissue repair and inflammation models, researchers often pair TB-500 Fragment (17–23) with:</p> <ul> <li>BPC-157 – known for synergistic effects on tendon, ligament, and muscle repair</li> <li>Thymosin Alpha-1 – for immune regulation and systemic recovery</li> <li>SS-31 – for mitochondrial support during injury recovery</li> <li>Ipamorelin – a growth hormone secretagogue to promote regenerative pathways</li> </ul> <h3>Safety and Research Profile</h3> <p>As a synthetic peptide fragment, TB-500 (17–23) is non-toxic, non-hormonal, and has not demonstrated adverse side effects in laboratory models. It does not interfere with hepatic, renal, or hormonal functions. Mild injection site irritation may occur with improper dilution or technique. Always follow lab safety protocols when reconstituting with bacteriostatic water or similar solvents.</p> <h3>USA Shipping and Research-Grade Quality</h3> <p>Peptide Hubs provides <strong>USA domestic shipping</strong> for TB-500 Fragment (17–23) 10 mg, ensuring fast and discreet delivery for certified labs and research institutions. All peptide products are manufactured under GMP-compliant conditions for research use only. Explore our complete regenerative category including GHK-Cu 50 mg and CJC-1295 no DAC.</p> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
N-Acetylated Synthetic Heptapeptide
Peptide Sequence
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH
Peptide Length
7 Amino-Acid Residues
Structural Origin
Thymosin β4 Residues 17–23
Terminal Form
N-Acetylated · C-Terminal Free Acid
Molecular Formula
C₃₈H₆₈N₁₀O₁₄
Molecular Weight
889.0 g/mol
Parent Peptide
Thymosin β4
Parent Functional Region
LKKTETQ Actin-Binding Region
Research Status
Experimental / Preclinical

Chat on WhatsApp